In the US for instance, the overweight condition affects around a third of the nation’s population, according to the World Health Organization. A study published at the peer reviewed journal General Dentistry mentions that obesity is not only a risk factor for diabetes, heart ailments and various cancer types, but is also a contributor to gum affliction.
Charlene Krejci, lead author of the research undertaking provides details on the aforementioned linkage, pointing out that the obese anatomy continually generates cytokines, amino acids with anti-inflammatory attributes. These compounds act as a catalysts to gum disease by directly plaguing gum tissues or inhibiting the movement of blood within the same mouth region.
Oral health proponents have asserted that gum ailing is without doubt detrimental to the teeth’s anchoring frameworks and environs. AGD spokesman Samer G. Shamoon calls for a multidimensional approach in addressing the concern, entailing daily brushing and flossing, proper rinsing, together with frequent professional cleansing.
World Vaccine Congress – April 10-12, 2017, Washington D.C.
The 17th Annual World Vaccine Congress will take place April 10-12, 2017, Washington D.C. The global vaccine industry will meet to discuss both commercial and scientific issues around “regulation, strategy, manufacturing, trials, partnering, influenza, cancer, emerging diseases and veterinary vaccines.”
For more information, visit the website https://goo.gl/nJ2bZ1
In all our frenzy over the latest gadget or piece of biotechnology we can often forget to consider the ethical ramifications of scientific progress. Where, exactly, do we draw the line? What sorts of ethical considerations must we take into account, especially as we break boundaries that have never been broken before? Take a look at this insightful Ted Talk and decide for yourself.
Around November of last year the UK biotech firm Oxitec created a strain of Aedes aegypti- a species of mosquito responsible for spreading the Zika virus- that was designed to spread a lethal gene and dramatically cut down mosquito populations. The FDA’s Center for Veterinary Medicine was put in charge of trial runs and recently cleared its test release of mosquitos last August.
However, there has been some controversy over the FDA gaining the responsibility of overseeing the environmental impact of mosquitos, a role that has traditionally gone to the EPA. “Without relevant expertise, not surprisingly the FDA has been ill-equipped to review the application expeditiously,” wrote attorney John Cohrssen and physician and former FDA official Henry Miller in a Forbes op-ed last January.
In response, the FDA explained that the product (genetically engineered mosquitos) should be considered as pesticides (more specifically, biological pesticides). This means that if finalized, the responsibility for future GE mosquito strains would ultimately fall to the EPA for review.